» Articles » PMID: 30806029

CFTR Dysfunction Increases Endoglin and TGF-β Signaling in Airway Epithelia

Overview
Journal Physiol Rep
Specialty Physiology
Date 2019 Feb 27
PMID 30806029
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Endoglin (ENG) regulates signaling by transforming growth factor-β (TGF-β), a genetic modifier of cystic fibrosis (CF) lung disease severity. We hypothesized that ENG mediates TGF-β pathobiology in CF airway epithelia. Comparing CF and non-CF human lungs, we measured ENG by qPCR, immunoblotting and ELISA. In human bronchial epithelial cell lines (16HBE), we used CFTR siRNA knockdown and functional inhibition (CFTR -172) to connect loss of CFTR to ENG synthesis. Plasmid overexpression of ENG assessed the direct effect of ENG on TGF-β transcription and signal amplification in 16HBE cells. We found ENG protein to be increased more than fivefold both in human CF bronchoalveolar fluid (BALF) and human CF lung homogenates. ENG transcripts were increased threefold in CF, with a twofold increase in TGF-β signaling. CFTR knockdown in 16HBE cells tripled ENG transcription and doubled protein levels with corresponding increases in TGF-β signaling. Plasmid overexpression of ENG alone nearly doubled TGF-β1 mRNA and increased TGF-β signaling in 16HBE cells. These experiments identify that loss of CFTR function increases ENG expression in CF epithelia and amplifies TGF-β signaling. Targeting ENG may offer a novel therapeutic opportunity to address TGF-β associated pathobiology in CF.

Citing Articles

Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis.

H Oz H, Cheng E, Di Pietro C, Tebaldi T, Biancon G, Zeiss C Cell Rep. 2022; 41(11):111797.

PMID: 36516754 PMC: 9833830. DOI: 10.1016/j.celrep.2022.111797.


Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial-mesenchymal transition.

Quaresma M, Botelho H, Pankonien I, Rodrigues C, Pinto M, Costa P Life Sci Alliance. 2022; 5(9).

PMID: 35500936 PMC: 9060002. DOI: 10.26508/lsa.202101326.


Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis.

Conese M, Di Gioia S Pathophysiology. 2022; 28(1):155-188.

PMID: 35366275 PMC: 8830450. DOI: 10.3390/pathophysiology28010011.


Impact of KLF4 on Cell Proliferation and Epithelial Differentiation in the Context of Cystic Fibrosis.

Sousa L, Pankonien I, Simoes F, Chanson M, Amaral M Int J Mol Sci. 2020; 21(18).

PMID: 32937756 PMC: 7555189. DOI: 10.3390/ijms21186717.


CFTR dysfunction increases endoglin and TGF-β signaling in airway epithelia.

Nicola T, Kabir F, Coric T, Wall S, Zhang W, James M Physiol Rep. 2019; 7(4):e13977.

PMID: 30806029 PMC: 6389738. DOI: 10.14814/phy2.13977.

References
1.
Bremer L, Blackman S, Vanscoy L, McDougal K, Bowers A, Naughton K . Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet. 2008; 17(14):2228-37. PMC: 2902288. DOI: 10.1093/hmg/ddn123. View

2.
Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T . Latent TGF-β structure and activation. Nature. 2011; 474(7351):343-9. PMC: 4717672. DOI: 10.1038/nature10152. View

3.
Kelly M, Trudel S, Brouillard F, Bouillaud F, Colas J, Nguyen-Khoa T . Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition. J Pharmacol Exp Ther. 2010; 333(1):60-9. DOI: 10.1124/jpet.109.162032. View

4.
Harris W, Muhlebach M, Oster R, Knowles M, Noah T . Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis. Pediatr Pulmonol. 2009; 44(11):1057-64. DOI: 10.1002/ppul.21079. View

5.
Massague J . TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012; 13(10):616-30. PMC: 4027049. DOI: 10.1038/nrm3434. View